Sanofi-Aventis SA Company Information
Employees at Sanofi-Aventis SA
Showing 14 of 67383| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Junior Product Manager | @novartis.com | - |
London, Londo | VIEW PROFILE |
| Clinical Trial Manager Scandinavia Oncology | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @allergan.com | - |
VIEW PROFILE | |
| Pharmacovigilance Trainee | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @sanofipasteur.com | - |
VIEW PROFILE | |
| Pharmacometrician | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @natera.com | - |
Cagua, Barinas | VIEW PROFILE |
| Clinical Research Director | @sanofi.com | - |
VIEW PROFILE | |
| Ectd Administrative Coordinator-Contract | @bayer.com | - |
York, Ontario | VIEW PROFILE |
| Representante Medico Linea Pediatrica | @astrazeneca.com | - |
Veracruz, Yucatan | VIEW PROFILE |
| Dipendente | @sanofi.com | - |
VIEW PROFILE | |
| Support Et Expertise Eprocurement France | @sanofi.com | - |
Lyon, Rhone-Alpes | VIEW PROFILE |
| Medical Information | @sanofi.com | - |
Pennsylvania | VIEW PROFILE |
| Employee | @novartis.com | - |
Winnberg, Bremen | VIEW PROFILE |
Junior Product Manager
London, Londo 
Clinical Trial Manager Scandinavia Oncology
Employee
Pharmacovigilance Trainee
Employee
Pharmacometrician
Employee
Cagua, Barinas Clinical Research Director
Ectd Administrative Coordinator-Contract
York, Ontario Representante Medico Linea Pediatrica
Veracruz, Yucatan Dipendente
Support Et Expertise Eprocurement France
Lyon, Rhone-Alpes Medical Information
Pennsylvania Employee
Winnberg, Bremen 
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Sanofi-Aventis SA's Email Format
We found 3 email formats used by Sanofi-Aventis SA employees. The most common Sanofi-Aventis SA email format is first.last ex.(jane.doe@sanofi.com) being used 93% of the time.
| FORMAT | % | ||
|---|---|---|---|
| First.last | jane.doe@sanofi.com | 93% | |
| First_initial Last | jdoe@sanofi.com | 3% | |
| Others | @sanofi.com | 2% |
